Tocilizumab, an IL-6R antibody, is clinically used in the treatment of various autoimmune diseases, such as rheumatoid arthritis, which is associated with pathologically hyper-activated IL-6 signalling [47]. This evidence concerns the gene IL6R and rheumatoid arthritis.